Clinical Trial Update: Double Blind Trial of DC Polarization in FTD [Phase 2]

View source ↗

Summary

A completed Phase 2 double-blind trial evaluating DC polarization as a treatment for frontotemporal dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Dementia | Phase 2 | Status: COMPLETED